RP-HPLC Assay for Estimation of Pitavastatin in Bulk and Pharmaceutical Dosage Forms
DOI:
https://doi.org/10.37285/ijpsn.2014.7.1.5Abstract
Reverse phase high performance liquid chromatographic (RP-HPLC) method was developed and validated for the estimation of pitavastatin in tablet dosage form. A Phenomenex Luna C18, 150×4.6 mm i.d, 5 µm particle size with mobile phase consisting of buffer 0.01M potassium dihydrogen ortho phosphate pH (3.75) adjusted with dilute orthophosphoric and acetonitrile in the ratio of 20:80 v/v was used. The flow rate was 1.2 mL/min and eluents were monitored at 248 nm. The retention time was 4.1min. The detector response was linear in the concentration of 25-150 µg/mL, with the regression coefficient of 0.9998. Quantification was done by calculating area of the peak and the limit of detection and limit of quantification were 1.9 µg/mL and 5.7 µg/mL respectively. The percentage assay of pitavastatin was 101.1%. The results of study showed that the proposed RP-HPLC method is simple, rapid, precise and accurate which is useful for the routine determination of pitavastatin in bulk drug and in its pharmaceutical dosage forms.
Downloads
Metrics
Keywords:
HPLC, Pitavastatin, Method validation, RP-HPLC, LOQ
Downloads
Published
How to Cite
Issue
Section
References
Ando H, Tsuruoka S, Yanagihara H, Sugimoto K, Miyata M et al. (2005). Effects of grapefruit juice on the pharmacokinetics ofPitavastatin and Atorvastatin. Br J Clin Pharmacoly. 60(5): 494-497.
Tian L, Huang Y, Jia Y, Hua L and Li Y (2008). Development and validation of a liquid chromatography-tandem mass spectrometric assay for pitavastatin and its lactone in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 865(1-2): 127-132.
Panchal HJ, Suhagia BN, Patel MM and Patel BH (2009). Estimation of Pitavastatin calcium in tablet dosage forms by column liquid chromatography and ultraviolet spectrophotometry. J AOAC Int. 92(1): 158-64.
Hui CK, Cheung BM and Lau GK (2005). Pharmacokinetics of Pitavastatin in subjects with Child-Pugh A and B cirrhosis. Br J ClinPharmacol. 59(3): 291-297.
Fujino H, Yamada I, Shimada S and Yoneda M (2001). Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay-inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase. J Chromatogr B Biomed Sci Appl. 757(1): 143-150.
Kojima J, Fujino H, Yosimura M, Morikawa H and Kimata H (1999). Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection. J Chromatography B Biomed Sci Appl. 724(1): 173-180.
Ojha A, Guttikar S, Vayeda C and Padh (2007). Determination of Pitavastatin from Human Plasma Using High Performance Liquid Chromatography with Fluorescence Detection. Se Pu. 25(5): 715-718.
Satheesh Kumar N and Baghyalakshmi J (2007). Determination and Quantification of Pitavastatin Calcium in Tablet Dosage Formulation by HPTLC Method. Analytical letters. 40(14): 2625-2632.
Panchal HJ, Suhagia BN, Patel NJ and Patel BH (2008). A simple and sensitive HPTLC method for quantitative analysis of Pitavastatin calcium in tablets. J Planar Chromatography. 21(4): 267-270.
Reviewer Guidance (1994). Validation of analytical procedures-methodology.
ICH/CPMP guidelines Q2B (1996). Validation of Analytical Procedures- Methodology.
ICH International conference on Harmonization (1996). Validation of Analytical Procedures: Methodology.
Grushka E, Brown PR and Brown R (2000). Advances in chromatography 40: 443-454.
Ahuja S and scypinski S (2001) (Eds) handbook of Modern Pharmaceutical analysis, Academic press, New York, 415-44
